COVID-19: UN health agency issues conditional advice against using remdesivir
Patients with COVID-19 should not be given the antiviral drug remdesivir “regardless of disease severity”, the UN World Health Organization (WHO) said on Friday.
Nonetheless, describing its recommendation as “conditional”, as opposed to “strong”, WHO stressed that data from a global trial on the efficacy of remdesivir was inconclusive, and that further trials should continue into its use for more vulnerable patients.
“We recommend a conditional recommendation – I want to highlight that - against the use of remdesivir in hospitalised patients with COVID-19 regardless of disease severity,” said Dr Janet Diaz, Head of Clinical Care at WHO, during a virtual press conference in Geneva.
According to data from the WHO-led Solidarity trial which was then examined by a panel of international experts behind the recommendation, “possibly remdesivir can lead to 29 fewer deaths per 1,000 patients or up to 11 more deaths per 1000 patients”, Dr Diaz said. “So you can see that …the confidence interval are relatively large…there was no evidence that there was any important effect on mortality, on the need for mechanical ventilation or the time to clinical improvement.”
But this did “not prove” that the antiviral “had no benefit at all”, Dr Diaz insisted. “There could still be potential small benefit, maybe in a health sub-group which is why the panel also recommended continued trials, continued enrolment into clinical trials.”
The WHO official explained that this might be “severe patients versus critical patients” or whether the antiviral is used “early versus late”.
Dr Bram Rochwerg, who was among the experts advising WHO, noted that there would likely be regional “variations” in the use of remdesivir.
While a minority of people will still choose to use it, the majority would not, based on the available data, he said.
“There may be groups (who might benefit) and the data was a bit more of a close call, so that’s why we felt strongly that trials need to continue using remdesivir and studying remdesivir and looking to see if there are specific groups that might, that might benefit,” he said. “We were very explicit that we do believe that these studies need to continue (and) Solidarity is continuing.”
Although the remdesivir development mirrors similar attempts to use other antivirals against the new coronavirus, Dr Diaz said there was no reason to lose hope in the fight against COVID-19.
“I do think there is a tremendous global effort to investigate treatments. You know, I think a lot of interest was done upfront with the repurposed of drugs, repurposed antivirals, you know we saw that with other repurposed drugs such as hydroxychloroquine, lopinavir, and there was a big push to try to test these and they’ve been tested and unfortunately, we just haven’t, you know, the results haven’t been as promising as we had hoped. But I don’t want to forget that we do have one lifesaving drug and even though it’s a repurposed old, old drug dexamethasone, a corticosteroid, we do know that that does reduce mortality, save lives of patient with severe and critical so there is something.”
Latest data from WHO indicates that eight in 10 people infected with COVID report mild symptoms, Dr Diaz said.
“Since the beginning (of the pandemic)…about 80 per cent of people have, you know, mild disease, a proportion maybe moderate disease and then only a small proportion, a smaller proportion, 20 per cent go on to develop severe or critical disease, and critical disease is a small, small portion, it’s five per cent or less, and that is…and that seems to be kind of consistent I think through the literature so most patients do have, if they have mild disease, self-limiting disease, they get better on their own, their immune system kicks in and they get better.”
Nonetheless, there are reports of more “persistent longer-term symptoms”, Dr Diaz noted. “So even though they don’t get severe disease there can be some persistent symptoms that lasts longer than one would have hoped for.”
1
1
1
Edited News | OHCHR , UNOG
“Deadly attacks on distraught civilians trying to access the paltry amounts of food aid in Gaza, are unconscionable. For a third day running, people were killed around an aid distribution site run by the Gaza Humanitarian Foundation. This morning, we have received information that dozens more people were killed and injured,” Jeremy Laurence UN Human Rights spokesperson said at the biweekly press briefing in Geneva.
1
1
1
Edited News | OCHA
Gaza ‘hungriest place on earth’ with aid stymied – UN humanitarians
Starving Gazans continue to be deprived of aid as international relief efforts are being severely constrained by the Israeli authorities, the UN humanitarian affairs coordination office OCHA said on Friday.
1
1
1
Edited News | OCHA , UNRWA
As a controversial United States and Israel-backed aid distribution plan gets underway in Gaza, the UN called on Tuesday for an “immediate surge” of its own pre-positioned supplies to help prevent starvation.
1
1
1
Edited News | OHCHR
UN Human Rights Office Spokesperson Ravina Shamdasani today urged Ugandan President Yoweri Museveni to reject a bill that was recently endorsed by parliament allowing trials of civilians in military courts. The Uganda People’s Defence Forces Amendment Bill 2025, which was passed on 20 May and now awaits presidential signature to become law, among others broadens the jurisdiction of military courts, authorising them to try a wide range of offences against civilians.
1
1
1
Edited News | OHCHR
UN Human Rights Office spokesperson Seif Magango today warned of a further deterioration in the human rights situation in South Sudan at the bi-weekly briefing in Geneva.
1
1
1
Edited News | OCHA , WHO
Syria: ‘Staggering’ needs amid insecurity, health care crisis - UN humanitarians
Millions of people in Syria continue to face mortal danger from unexploded munitions, disease and malnutrition and urgent support is required, UN humanitarians said on Friday.
1
1
1
Edited News | UNRWA , OCHA , WHO
UN life-saving aid allowed to trickle into Gaza as civilian needs mount
Amid calls for more humanitarian trucks to enter the food and medicine-deprived Palestinian enclave of Gaza, UN humanitarians have received permission from Israel for “around 100” more aid trucks to cross into the Strip after only five were let in yesterday, But the scale of relief efforts allowed remains entirely insufficient to meet the urgent needs of people there, humanitarian workers say.
1
1
1
Edited News
A war reporter from Lebanon who lost a limb in the line of duty is calling for an end to impunity for attacks against journalists.
1
1
1
Edited News | ITU
The International Telecommunication Union (ITU) commemorated 160 years dedicated to connecting the world on Saturday, 17 May in Geneva, Switzerland, during the annual World Telecommunication and Information Society Day.
1
1
1
Edited News | WHO , OCHA
Gazans ‘in terror’ after another night of deadly strikes and siege
Amid reports that Israeli strikes across Gaza into Friday killed at least 64 people, aid teams once again pushed back strongly at allegations that aid is being diverted to Hamas and pleaded for the blockade to end.
1
1
1
Edited News | OHCHR , UNOG
Deportations over recent months of large numbers of non-nationals from the United States of America, especially to countries other than those of their origin, raise a number of human rights concerns, the UN Human Rights Chief Volker Türk warned on Tuesday.
1
1
1
Edited News | WHO
Gaza: Over 50 child malnutrition deaths amid aid blockade; entire generation will be ‘permanently affected’ - WHO
In the aid desert of Gaza, malnourished children are dying while survivors can expect a lifetime of dire health problems, the UN World Health Organization (WHO) said on Tuesday.